GLP-1 agonists linked to significantly lower long-term risk of knee replacement

MedicalXpress | 六月 02, 2026

GLP-1 receptor agonist drugs, used for the treatment of diabetes—and more recently, weight loss—are associated with a significantly lower long-term risk of knee replacement surgery as a result of osteoarthritis, finds an analysis of medical records data, published in the open-access journal Regional Anesthesia & Pain Medicine.